The Value of FDA Pre-Submission Meetings & Enhancements under PDUFA VI
Update Magazine | November/December 2017
Getting by with a Little Help from Their Friends: FDA Using External Experts to Enhance Biomarker Qualification and Enable Precision GalleryGetting by with a Little Help from Their Friends: FDA Using External Experts to Enhance Biomarker Qualification and Enable Precision
Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Publications, Volume 72.4
Getting by with a Little Help from Their Friends: FDA Using External Experts to Enhance Biomarker Qualification and Enable Precision
Food and Drug Law Journal | Volume 72 | Number 4
Letter to the Editor
Food and Drug Law Journal | Volume 72 | Number 4
Editorial or Ad? FTC’s Native Advertising Guidelines and Challenges for Industry GalleryEditorial or Ad? FTC’s Native Advertising Guidelines and Challenges for Industry
Drugs, Medical Devices, Biologics, Event, Food, Dietary Supplements, Cosmetics, General Webinars, On-demand Webinar, Tobacco Products
Editorial or Ad? FTC’s Native Advertising Guidelines and Challenges for Industry
Recorded November 29, 2017 | On-Demand Webinar
Development of Medical Devices: Best Practices for Safeguarding Your IP and FDA Rights
Recorded November 17, 2017 | On-Demand Webinar
Drug Quality Security Act Conference
November 15, 2017 I Washington, DC
FDA, USDA, and EPA: Inter-Agency Overlap and Jurisdictional Boundaries
Recorded November 9, 2017 | On-Demand Webinar
Compounding the Off-Label Promotion Debate: How FDA Could Regulate the Promotion of Unapproved Drugs GalleryCompounding the Off-Label Promotion Debate: How FDA Could Regulate the Promotion of Unapproved Drugs
Archived Publication, Drugs, Medical Devices, Biologics, Publications, Update Magazine, Update September/October 2017
Compounding the Off-Label Promotion Debate: How FDA Could Regulate the Promotion of Unapproved Drugs
Update Magazine | September/October 2017
Intellectual Property for the Food and Drug Law Professional: Issues that Arise in the Product Development Process GalleryIntellectual Property for the Food and Drug Law Professional: Issues that Arise in the Product Development Process
Archived Publication, Drugs, Medical Devices, Biologics, Publications, Update Magazine, Update September/October 2017
Intellectual Property for the Food and Drug Law Professional: Issues that Arise in the Product Development Process
Update Magazine | September/October 2017
The “New” NDC: Are You Aware of FDA’s Rollout of the New Unique Medical Device Identifier (UDI) and Its Potential Future Impact on Payer Claims Forms? GalleryThe “New” NDC: Are You Aware of FDA’s Rollout of the New Unique Medical Device Identifier (UDI) and Its Potential Future Impact on Payer Claims Forms?
Archived Publication, Drugs, Medical Devices, Biologics, Publications, Update Magazine, Update September/October 2017
The “New” NDC: Are You Aware of FDA’s Rollout of the New Unique Medical Device Identifier (UDI) and Its Potential Future Impact on Payer Claims Forms?
Update Magazine | September/October 2017
